A higher level of DNA methylation in the KOR (OPRK1) promoter CpG site was observed in patients with AD as compared to controls and this high methylation of OPRK1 could contribute to the risk of AD through its downregulation of gene expression (Ji et al., 2015). Here, OPRK1 is linked to Alzheimer disease.